The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Self-citationThe cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
Stopak, K., de Noronha, C., Yonemoto, W., & Greene, W. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00353-8 · Cited by 732
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 708
The HIV A (sor) gene product is essential for virus infectivity
Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., & Martin, M. A. (1987) · Nature · doi:10.1038/328728a0 · Cited by 479
Cited by
Retroviral restriction by APOBEC proteins
Harris, R. S., & Liddament, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1489 · Cited by 654
Self-citationHarris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 551
Self-citationThe AID/APOBEC family of nucleic acid mutators
Conticello, S. G. (2008) · Genome Biology · doi:10.1186/gb-2008-9-6-229 · Cited by 546
Self-citationAncient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
Intrinsic immunity: a front-line defense against viral attack
Bieniasz, P. D. (2004) · Nature Immunology · doi:10.1038/ni1125 · Cited by 454
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Self-citationHuman APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection
Jäger, S., Kim, D. Y., Hultquist, J. F., Shindo, K., LaRue, R. S., Kwon, E., Li, M., Anderson, B. D., Yen, L., Stanley, D., et al. (2012) · Nature · doi:10.1038/nature10693 · Cited by 352
Self-citationHIV-1 Vif, APOBEC, and Intrinsic Immunity
Goila-Gaur, R., & Strebel, K. (2008) · Retrovirology · doi:10.1186/1742-4690-5-51 · Cited by 342
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Koning, F. A., Newman, E. N. C., Kim, E.-Y., Kunstman, K. J., Wolinsky, S. M., & Malim, M. H. (2009) · Journal of Virology · doi:10.1128/jvi.01089-09 · Cited by 336
Holmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 308
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
Chelico, L., Pham, P., Calabrese, P., & Goodman, M. F. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1086 · Cited by 306
Suspène, R., Guétard, D., Henry, M., Sommer, P., Wain-Hobson, S., & Vartanian, J.-P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408223102 · Cited by 304
Yu, Y., Xiao, Z., Ehrlich, E. S., Yu, X., & Yu, X.-F. (2004) · Genes & Development · doi:10.1101/gad.1250204 · Cited by 302
Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M., & Gabuzda, D. (2004) · Genes & Development · doi:10.1101/gad.1249904 · Cited by 296
Bogerd, H. P., Doehle, B. P., Wiegand, H. L., & Cullen, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307713101 · Cited by 295
Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors
Cullen, B. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1067-1076.2006 · Cited by 284
APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
Zennou, V., Perez-Caballero, D., Göttlinger, H., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12058-12061.2004 · Cited by 281
APOBEC proteins and intrinsic resistance to HIV-1 infection
Malim, M. H. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0185 · Cited by 280
Gallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M., & Malim, M. H. (2007) · Journal of Virology · doi:10.1128/jvi.02287-06 · Cited by 279
Mbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00272-07 · Cited by 274
Self-citationT-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction
Zhang, W., Du, J., Evans, S. L., Yu, Y., & Yu, X.-F. (2012) · Nature · doi:10.1038/nature10718 · Cited by 264
Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif
Guo, Y., Dong, L., Qiu, X., Wang, Y., Zhang, B., Liu, H., Yu, Y., Zang, Y., Yang, M., & Huang, Z. (2014) · Nature · doi:10.1038/nature12884 · Cited by 202
APOBEC Enzymes as Targets for Virus and Cancer Therapy
Olson, M. E., Harris, R. S., & Harki, D. A. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.10.007 · Cited by 164
Self-citationRatcliff, J., & Simmonds, P. (2021) · Virology · doi:10.1016/j.virol.2020.12.018 · Cited by 108
Multifaceted antiviral actions of APOBEC3 cytidine deaminases
Chiu, Y.-L., & Greene, W. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.003 · Cited by 72
Das, P., Xu, W. K., Gautam, A. K. S., Lozano, M. M., & Dudley, J. P. (2022) · mBio · doi:10.1128/mbio.02953-21 · Cited by 5
Metadata
- Authors
- Conticello, S. G., Harris, R. S., & Neuberger, M. S.
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 13
- Issue
- 22
- Pages
- 2009-2013
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W2040313539
- Cited by
- 469
- References
- 21
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.